Swedbank Robur Medica
- Namn
- Swedbank Robur Medica
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 11 031 943 757 SEK
- Likvida medel
- 244 356 302 SEK
- Övriga tillgångar och skulder
- 19 920 319 SEK
- Antal innehav
- 61
- Aktiv risk
- 4,70
- Standardavvikelse 24 månader
- 14,79
- Jämförelseindex
- MSCI World Health Care 10/40 Net
- Förvaltningsavgift
- 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| United Health | 863 993 110 SEK | 7,83% | Health Care |
| Roche | 625 842 857 SEK | 5,67% | Health Care |
| Merck | 510 557 808 SEK | 4,63% | Health Care |
| Thermo Fisher Scientific | 470 504 709 SEK | 4,26% | Health Care |
| Abbott Laboratories | 461 285 547 SEK | 4,18% | Health Care |
| Sanofi | 454 719 746 SEK | 4,12% | Health Care |
| AstraZeneca | 404 523 815 SEK | 3,67% | Health Care |
| Centene | 394 399 501 SEK | 3,58% | Health Care |
| Horizon Therapeutics | 372 463 780 SEK | 3,38% | Health Care |
| Alexion Pharmaceuticals | 372 107 355 SEK | 3,37% | Health Care |
| Amgen | 334 216 621 SEK | 3,03% | Health Care |
| Takeda Pharmaceutical | 310 636 361 SEK | 2,82% | Health Care |
| Vertex Pharmaceuticals | 265 910 707 SEK | 2,41% | Health Care |
| Edward Lifesciences | 229 264 667 SEK | 2,08% | Health Care |
| Novo Nordisk | 227 506 264 SEK | 2,06% | Health Care |
| Viatris | 220 081 557 SEK | 1,99% | Health Care |
| Swedish Orphan Biovitrum | 215 930 000 SEK | 1,96% | Health Care |
| Intuitive Surgical | 214 997 989 SEK | 1,95% | Health Care |
| Exelixis | 191 198 019 SEK | 1,73% | Health Care |
| Livanova | 187 594 763 SEK | 1,70% | Health Care |
| Eli Lilly | 180 258 902 SEK | 1,63% | Health Care |
| UCB | 175 721 737 SEK | 1,59% | Health Care |
| Hologic | 160 894 284 SEK | 1,46% | Health Care |
| Ionis Pharmaceuticals | 141 622 961 SEK | 1,28% | Health Care |
| Cooper Companies | 140 237 832 SEK | 1,27% | Health Care |
Branscher
Källa: Finansinspektionen.